PPM2 ECONOMIC VALUE AND UNCERTAINTY OF EXPANDED MULTIGENE PANELS FOR HEREDITARY BREAST AND OVARIAN CANCER SCREENING: ALL EXPANDED PANELS MAY NOT YET BE READY FOR PRIME TIME